abstract |
The present invention relates to drugs metabolized by cytochrome P450 monooxygenase (or pharmaceutically acceptable salts, esters and prodrugs thereof) comprising co-administration of ritonavir or pharmaceutically acceptable salts, esters and prodrugs thereof. Disclosed are compositions and methods for improving the pharmacokinetics of drugs. |